GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Coretech 5 (XPAR:MLCOT) » Definitions » EV-to-EBITDA

Coretech 5 (XPAR:MLCOT) EV-to-EBITDA : -17.95 (As of May. 18, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Coretech 5 EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Coretech 5's enterprise value is €0.36 Mil. Coretech 5's EBITDA for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.02 Mil. Therefore, Coretech 5's EV-to-EBITDA for today is -17.95.

The historical rank and industry rank for Coretech 5's EV-to-EBITDA or its related term are showing as below:

XPAR:MLCOT' s EV-to-EBITDA Range Over the Past 10 Years
Min: -48.03   Med: -12.09   Max: -5.24
Current: -17.95

During the past 9 years, the highest EV-to-EBITDA of Coretech 5 was -5.24. The lowest was -48.03. And the median was -12.09.

XPAR:MLCOT's EV-to-EBITDA is ranked worse than
100% of 709 companies
in the Drug Manufacturers industry
Industry Median: 15.03 vs XPAR:MLCOT: -17.95

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-18), Coretech 5's stock price is €0.02. Coretech 5's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.004. Therefore, Coretech 5's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Coretech 5 EV-to-EBITDA Historical Data

The historical data trend for Coretech 5's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coretech 5 EV-to-EBITDA Chart

Coretech 5 Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only -37.96 -11.18 -16.46 -9.81 -28.01

Coretech 5 Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only -37.96 -11.18 -16.46 -9.81 -28.01

Competitive Comparison of Coretech 5's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Coretech 5's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coretech 5's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Coretech 5's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Coretech 5's EV-to-EBITDA falls into.



Coretech 5 EV-to-EBITDA Calculation

Coretech 5's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.359/-0.02
=-17.95

Coretech 5's current Enterprise Value is €0.36 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Coretech 5's EBITDA for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Coretech 5  (XPAR:MLCOT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Coretech 5's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.02/-0.004
=At Loss

Coretech 5's share price for today is €0.02.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Coretech 5's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Coretech 5 EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Coretech 5's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Coretech 5 (XPAR:MLCOT) Business Description

Traded in Other Exchanges
N/A
Address
5 rue de Castiglione, Paris, FRA, 75 001
Coretech 5 Formerly Gour Medical AG is a pharmaceutical company. It develops and markets veterinary medicines and specialist pet. Its products include food supplements or nutraceuticals or related medical devices. The products are dedicated to the treatment of pain, allergies, behavioral disorders and improvement of quality of life. It sells its product under the brand Weedley.

Coretech 5 (XPAR:MLCOT) Headlines

No Headlines